Browsing Tag
intranasal
Bharat Biotech’s intranasal COVID-19 vaccine to cost ₹800 for private markets
Image for representational purposes only.
| Photo Credit: The Hindu
Hyderabad-based Bharath Biotech said Tuesday that its nasally administered vaccine, iNCOVACC, would be available for public use from the fourth week of January and cost…
Bharat Biotech’s Intranasal COVID-19 vaccine gets CDSCO approval
Representational image. AP…
The nose-brain pathway: Exploring the role of trigeminal nerves in delivering intranasally…
Intranasal (in.) administration has been garnering increasing popularity as a non-invasive approach to deliver drugs directly to the brain. This approach involves the respiratory or olfactory epithelia of the nasal mucosa through which the…
Intranasal COVID vaccine that works against variants in animals
An intranasal vaccine against SARS-CoV-2 could quickly get to the respiratory tract, where the virus most commonly causes symptoms. And a spray or droplets could be a more palatable option for people who fear needles. But so far, only a few…
COVID-19: India’s first intranasal vaccine by Bharat Biotech gets drug panel’s nod for…
The Central Drugs Standard Control Organisation has approved the vaccine for primary immunisation against COVID-19 in the above 18 age group for 'restricted use in an emergency situation'…
Scientists develop effective intranasal mumps-based COVID-19 vaccine candidate: Results in animals…
New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting a dose up…
Study shows that intranasal Rx halts memory decay in experimental Alzheimer’s model
A research collaboration between scientists at LSU Health New Orleans and the Karolinska Institutet in Sweden has found that applying specialized pro-resolving lipid mediators intranasally arrested memory loss and brain degeneration in an…
Intranasal vaccines: What are they and how they can help against COVID-19
Bharat Biotech has received approval for Phase 3 clinical trials of its intranasal coronavirus booster dose from the Drugs Controller General of India (DCGI)
Bharat Biotech has…
Intranasal flu vaccine with nanoparticles offers robust protection
An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers in the Institute for Biomedical…